FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Suryaprakash Raichur

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Molecular Structure

Disorders

Hyperlipidemias

Co-author Network

Publications

TOP 3
Suryaprakash Raichur; R L Fitzsimmons; S A Myers; M A Pearen; Patrick Lau; N Eriksson; S M Wang; George E O Muscat
Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle.
Patrick Lau; Rebecca L Fitzsimmons; Suryaprakash Raichur; Shu-Ching M Wang; Adriane Lechtken; George E O Muscat
The orphan nuclear receptor, RORalpha, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity.
Michael A Pearen; Stephen A Myers; Suryaprakash Raichur; James G Ryall; Gordon S Lynch; George E O Muscat
The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Suryaprakash Raichur (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Suryaprakash Raichur; R L Fitzsimmons; S A Myers; M A Pearen; Patrick Lau; N Eriksson; S M Wang; George E O Muscat
Identification and validation of the pathways and functions regulated by the orphan nuclear receptor, ROR alpha1, in skeletal muscle.
Nucleic acids research 2010;38(13):4296-312.
2008: Patrick Lau; Rebecca L Fitzsimmons; Suryaprakash Raichur; Shu-Ching M Wang; Adriane Lechtken; George E O Muscat
The orphan nuclear receptor, RORalpha, regulates gene expression that controls lipid metabolism: staggerer (SG/SG) mice are resistant to diet-induced obesity.
The Journal of biological chemistry 2008;283(26):18411-21.
2008: Michael A Pearen; Stephen A Myers; Suryaprakash Raichur; James G Ryall; Gordon S Lynch; George E O Muscat
The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle.
Endocrinology 2008;149(6):2853-65.
2007: Suryaprakash Raichur; Patrick Lau; Bart Staels; George E O Muscat
Retinoid-related orphan receptor gamma regulates several genes that control metabolism in skeletal muscle cells: links to modulation of reactive oxygen species production.
Journal of molecular endocrinology 2007;39(1):29-44.
2007: Rakesh Kumar; Uma Ramachandran; Suryaprakash Raichur; Ranjan Chakrabarti; Rahul Jain
Synthesis and evaluation of N-acetyl-L-tyrosine based compounds as PPARalpha selective activators.
European journal of medicinal chemistry 2007;42(4):503-10.
2007: Rakesh Kumar; Uma Ramachandran; Smriti Khanna; Prasad Bharatam; Suryaprakash Raichur; Ranjan Chakrabarti
Synthesis, in vitro and in silico evaluation of l-tyrosine containing PPARalpha/gamma dual agonists.
Bioorganic & medicinal chemistry 2007;15(3):1547-55.
2005: Rakesh Kumar; Uma Ramachandran; Krishnamoorthy Srinivasan; Poduri Ramarao; Suryaprakash Raichur; Ranjan Chakrabarti
Design, synthesis and evaluation of carbazole derivatives as PPAR alpha/gamma dual agonists and antioxidants.
Bioorganic & medicinal chemistry 2005;13(13):4279-90.
2004: Uma Ramachandran; Alka Mital; Prasad Bharatam; Smriti Khanna; Poduri Rama Rao; Krishnamoorthy Srinivasan; Rakesh Kumar; Harmander Pal Singh Chawla; Chaman Lal Kaul; Suryaprakash Raichur; Ranjan Chakrabarti
Studies on some glitazones having pyridine as the linker unit.
Bioorganic & medicinal chemistry 2004;12(4):655-62.
2003: Ranjan Chakrabarti; Reeba K Vikramadithyan; Parimal Misra; Jagadheshan Hiriyan; Suryaprakash Raichur; Ravi K B Damarla; Cynthia Gershome; Juluri Suresh; Ramanujam Rajagopalan
Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.
British journal of pharmacology 2003;140(3):527-37.